An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...

Declines in ESA hyporesponsiveness are significantly associated with increased malignancy risk in patients with CKD not on dialysis.

Possibly quite ignored, nails are an important part of our fingers and toes. Though nails' primary function is to protect the tips of fingers and toes from injury, they also play a role in enhancing ...

Learn more about how this delicious green drink can block your body from absorbing iron and what you can do to avoid it ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

Shares of this biotech giant have lost 16.3% year to date compared with the industry’s decline of 2.7%. The stock has also ...

It's incredibly scary to experience a random symptom out of nowhere, especially when it won't go away. So when I saw Reddit ...

Puma Biotechnology remains undervalued despite steady neratinib sales and a promising, though early-stage, pipeline. Learn ...

During a live event, Fengting Yan, MD, PhD, discussed safety outcomes from the TROPION-Breast01 and supportive care for ...

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.